Biotech News
MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference
ir.macrogenics.com2026-05-06 14:58 EST
ROCKVILLE, MD , Sept. 02, 2025 (GLOBE NEWSWIRE) -- MacroGenics , Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that MacroGenics’ President & Chief Executive Officer, Eric Risser , will